Taho Pharmaceuticals Ltd. (TPEX:6467)

Taiwan · Delayed Price · Currency is TWD

178.00

-1.50 (-0.84%)

At close: Sep 3, 2026

Taho Pharmaceuticals Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2017
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '17 Dec 31, 2017
Revenue	1.98	8.41	-	1.07	6.36	12.4
Revenue Growth	-74.53%	-	-	-83.23%	-48.73%	-65.56%
Gross Profit	1.75	5.41	-	-0.07	5.06	-1.14
Operating Income	-242.57	-220.14	-170.13	-121.1	-66.71	-107.25
Net Income	-238.34	-214.4	-167.44	-120.68	-66.3	-137.14
Earnings Per Share	-4.58	-4.16	-3.69	-3.12	-1.84	-2.62
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Japan	0.08
United State	8.33
Total	8.41

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2017
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '17 Dec 31, 2017
Cash & Investments	299.77	389.98	495.87	229.77	106.3	128.63
Total Debt	8.57	11.31	16.65	21.62	-	0.91
Net Cash (Debt)	291.2	378.66	479.22	208.15	106.3	127.72
Net Cash Growth	-24.85%	-20.98%	130.22%	95.82%	-16.77%	-42.91%
Net Cash Per Share	5.60	7.36	10.56	5.37	2.96	2.44

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2017
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '17 Dec 31, 2017
Operating Cash Flow	-200.08	-203.73	-156.91	-104.22	-62.78	-136.46
Capital Expenditures	-4.98	-5.41	-8.82	-2.89	-0.83	-1.97
Free Cash Flow	-205.05	-209.14	-165.73	-107.1	-63.61	-138.44
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2017
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '17 Dec 31, 2017
Gross Margin	88.49%	64.29%	-	-6.75%	79.52%	-9.16%
Operating Margin	-12244.62%	-2617.59%	-	-11359.94%	-1049.20%	-864.87%
Pretax Margin	-12031.45%	-2549.32%	-	-11321.11%	-1042.75%	-1105.89%
Profit Margin	-12031.45%	-2549.32%	-	-11321.11%	-1042.75%	-1105.89%
FCF Margin	-10351.03%	-2486.80%	-	-10047.00%	-1000.49%	-1116.35%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2017
Period Ending	Sep '26 Sep 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '17 Dec 31, 2017
PS Ratio	4709.05	681.34	-	-	-	49.65